Artículos de revistas sobre el tema "Hypercholesteremia"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Hypercholesteremia".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Visavadiya, Nishant P. y A. V. R. L. Narasimhacharya. "AsparagusRoot Regulates Cholesterol Metabolism and Improves Antioxidant Status in Hypercholesteremic Rats". Evidence-Based Complementary and Alternative Medicine 6, n.º 2 (2009): 219–26. http://dx.doi.org/10.1093/ecam/nem091.
Texto completoKamalova, Aelita A. "Diet Therapy in Children with Hypercholesteremia". Current Pediatrics 19, n.º 4 (19 de septiembre de 2020): 309–15. http://dx.doi.org/10.15690/vsp.v19i4.2140.
Texto completoDietrich, Hans H. "Apolipoprotein E in Hypercholesteremia and Beyond". Stroke 38, n.º 7 (julio de 2007): 2036. http://dx.doi.org/10.1161/strokeaha.107.489856.
Texto completoLEWIS, S. "P514 Hypercholesteremia induces baroreceptro reflex dysfunction". European Heart Journal 24, n.º 5 (marzo de 2003): 81. http://dx.doi.org/10.1016/s0195-668x(03)93952-2.
Texto completoNAKAI, TSUGUHIKO. "Familial hypercholesteremia complicated by nephrotic syndrome." Nihon Naika Gakkai Zasshi 79, n.º 8 (1990): 1079–80. http://dx.doi.org/10.2169/naika.79.1079.
Texto completoHURLEY, D. "Hypercholesteremia induces enhanced circulating inflammatory activity". American Journal of Hypertension 17, n.º 5 (mayo de 2004): S242. http://dx.doi.org/10.1016/j.amjhyper.2004.03.648.
Texto completoLi, Nan F., Hong M. Wang, Jin Yang, Ling Zhou, Xiao G. Yao y Jing Hong. "Serum uric acid is associated with metabolic risk factors for cardiovascular disease in the Uygur population". Applied Physiology, Nutrition, and Metabolism 34, n.º 6 (diciembre de 2009): 1032–39. http://dx.doi.org/10.1139/h09-101.
Texto completoNichols, E. H. y M. R. Jaff. "Hypercholesteremia, Hypertension, and Antiplatelet Therapy in PAD". MD Conference Express 13, n.º 19 (1 de diciembre de 2013): 31. http://dx.doi.org/10.1177/155989771319015.
Texto completoKumawat, Vinod Bihari, Surendra Kumar Sharma, Uttam Kumar Sharma y Sudhir Sharma. "Effect of trikatu compound in hypercholesteremia- a clinical study". Environment Conservation Journal 16, n.º 1&2 (12 de junio de 2015): 57–61. http://dx.doi.org/10.36953/ecj.2015.161209.
Texto completoTokura, T. "Changes in Bruch's Membrane in Experimental Hypercholesteremia in Rats". Japanese Journal of Ophthalmology 43, n.º 4 (8 de julio de 1999): 337–38. http://dx.doi.org/10.1016/s0021-5155(99)00055-6.
Texto completoBARTON, M. "Hypercholesteremia induces cardiac concentric remodeling in the guinea pig". American Journal of Hypertension 17, n.º 5 (mayo de 2004): S165—S166. http://dx.doi.org/10.1016/j.amjhyper.2004.03.434.
Texto completoElbadawi, Ayman, Islam Y. Elgendy, Mohamed Omer, Mohamed Abdelazeem, Vijay Nambi, Chayakrit Krittanawong, Ravi S. Hira, Jacqueline Tamis-Holland, Christie Ballantyne y Hani Jneid. "Outcomes of Acute Myocardial Infarction in Patients with Familial Hypercholesteremia". American Journal of Medicine 134, n.º 8 (agosto de 2021): 992–1001. http://dx.doi.org/10.1016/j.amjmed.2021.03.013.
Texto completoYu, Lianlong, Qianrang Zhu, Yuqian Li, Pengkun Song y Jian Zhang. "Dietary Branched-Chain Amino Acids (BCAAs) and Risk of Dyslipidemia in a Chinese Population". Nutrients 14, n.º 9 (27 de abril de 2022): 1824. http://dx.doi.org/10.3390/nu14091824.
Texto completoNagaraj, Lavanya y Naveen Kumar Madalageri. "A comparative study of metabolic side effects of risperidone and olanzapine in the treatment of schizophrenia". International Journal of Basic & Clinical Pharmacology 8, n.º 11 (22 de octubre de 2019): 2561. http://dx.doi.org/10.18203/2319-2003.ijbcp20194803.
Texto completoKoo, Hui Chin, Lay Kim Tan, Geok Pei Lim, Chee Cheong Kee y Mohd Azahadi Omar. "Obesity and Its Association with Undiagnosed Diabetes Mellitus, High Blood Pressure and Hypercholesterolemia in the Malaysian Adult Population: A National Cross-Sectional Study Using NHMS Data". International Journal of Environmental Research and Public Health 20, n.º 4 (9 de febrero de 2023): 3058. http://dx.doi.org/10.3390/ijerph20043058.
Texto completoDidia, S. Claudia. "PCSK9-Inhibitors: A Review of a Novel Approach in Hypercholesteremia Management". Medical Science Review 1 (2014): 1–6. http://dx.doi.org/10.12659/msrev.890836.
Texto completoVerma, Isha, Antonio Fernandez y Paul Thompson. "FAMILIAL HYPERCHOLESTEREMIA: WHEN STATINS, EZETIMIBE & PCSK9 INHIBITORS ARE NOT ENOUGH". Journal of the American College of Cardiology 71, n.º 11 (marzo de 2018): A2439. http://dx.doi.org/10.1016/s0735-1097(18)32980-2.
Texto completoVerma, Isha, Paul D. Thompson y Antonio B. Fernandez. "Familial Hypercholesteremia: When Statins, Ezetimibe & PCSK9 Inhibitors Are Not Enough". Journal of Clinical Lipidology 12, n.º 2 (marzo de 2018): 545. http://dx.doi.org/10.1016/j.jacl.2018.03.043.
Texto completoValentine, V. G., L. Seoane, D. M. Fuchs, S. G. LaPlace, G. A. Lombard y D. E. Taylor. "Potential benefits of treating hypercholesteremia and hypertension in lung allograft recipients". Journal of Heart and Lung Transplantation 24, n.º 2 (febrero de 2005): S170. http://dx.doi.org/10.1016/j.healun.2004.12.105.
Texto completoMUNDAY, J. "Hypercholesteremia-induced changes in left ventricular geometry in the guinea pig". American Journal of Hypertension 17, n.º 5 (mayo de 2004): S168. http://dx.doi.org/10.1016/j.amjhyper.2004.03.441.
Texto completoFan, Jing, Caicui Ding, Weiyan Gong, Fan Yuan, Yanning Ma, Ganyu Feng, Chao Song y Ailing Liu. "The Relationship between Leisure-Time Sedentary Behaviors and Metabolic Risks in Middle-Aged Chinese Women". International Journal of Environmental Research and Public Health 17, n.º 19 (30 de septiembre de 2020): 7171. http://dx.doi.org/10.3390/ijerph17197171.
Texto completoZhang, Haoqiang, Rong Huang, Sai Tian, Ke An, Wenwen Zhu, Jijing Shi, Wuyou Cao y Shaohua Wang. "The CC Genotype of Insulin-Induced Gene 2 rs7566605 Is a Protective Factor of Hypercholesteremia Susceptible to Mild Cognitive Impairment, Especially to the Executive Function of Patients with Type 2 Diabetes Mellitus". BioMed Research International 2020 (10 de junio de 2020): 1–7. http://dx.doi.org/10.1155/2020/4935831.
Texto completoJha, Niharika y Vanya Narayan. "Multiple giant tuberous xanthomas with type IIa hypercholesteremia in a young male". Indian Journal of Dermatopathology and Diagnostic Dermatology 7, n.º 1 (2020): 38. http://dx.doi.org/10.4103/ijdpdd.ijdpdd_40_20.
Texto completoMiyayama, Takeshi, Shin-ichiro Miura, Tomo Komaki, Takashi Kuwano, Joji Morii, Hiroaki Nishikawa y Keijiro Saku. "Acute Myocardial Infarction in a 26-Year-Old Patient With Familial Hypercholesteremia". Journal of Clinical Medicine Research 8, n.º 7 (2016): 562–65. http://dx.doi.org/10.14740/jocmr2596w.
Texto completoYakimenko, O. y Ie Maznichenko. "COMPLEX HYPOLIPIDEMIC THERAPY OF PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS AND FAMILIAL HYPERCHOLESTEREMIA". Bulletin of Problems Biology and Medicine 1, n.º 2 (2019): 207. http://dx.doi.org/10.29254/2077-4214-2019-1-2-149-207-211.
Texto completoHyvärinen, Lea. "FLUORESCENCE CINEANGIOGRAPHIC AND HISTOLOGICAL STUDIES ON THE RABBIT EYE DURING EXPERIMENTAL HYPERCHOLESTEREMIA". Acta Ophthalmologica 46, n.º 1 (27 de mayo de 2009): 57–70. http://dx.doi.org/10.1111/j.1755-3768.1968.tb02495.x.
Texto completoHarper, Claudia, Radhika Seimon, Brendon Yee, Amanda Sainsbury y Elizabeth Cayanan. "Translating Evidence into Practice: A Case Study of Extended Use of a Very Low Energy Diet for Treatment of Co-Morbid Obesity and Chronic Disease". Recent Progress in Nutrition 2, n.º 2 (21 de febrero de 2022): 1. http://dx.doi.org/10.21926/rpn.2202015.
Texto completoBarrios, Vivencio y Carlos Escobar. "Fixed-dose combination of rosuvastatin and ezetimibe: treating hypercholesteremia according to cardiovascular risk". Expert Review of Clinical Pharmacology 14, n.º 7 (24 de mayo de 2021): 793–806. http://dx.doi.org/10.1080/17512433.2021.1925539.
Texto completoGodal, H. C., J. C. Lund y E. Sivertssen. "LIPIDS AND LIPOPROTEINS IN SERUM IN CASES OF FAMILIAL ESSENTIAL HYPERCHOLESTEREMIA AND XANTHOMATOSIS." Acta Medica Scandinavica 156, S319 (24 de abril de 2009): 125–34. http://dx.doi.org/10.1111/j.0954-6820.1956.tb06306.x.
Texto completoLi, Zhi-Zhao, Qiong Huang, Xiao-li Yang, Jieqiong Zeng, QI-Hui Wang, Hai-Ming Tang, Zhen-qiu Yu, Yu-Qing Song y Yang Liu. "Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia". Disease Markers 2022 (21 de abril de 2022): 1–9. http://dx.doi.org/10.1155/2022/2008556.
Texto completoRANA, MOHAMMAD MOHSIN, BADAR BASHIR, MUHAMMAD SAEED AKHTAR y Abaid Ur-Rehman. "TYPE 2 DIABETICS". Professional Medical Journal 14, n.º 02 (6 de septiembre de 2007): 337–43. http://dx.doi.org/10.29309/tpmj/2007.14.02.4900.
Texto completoYuefeng, Yu, Lin Zhiqi, Chen Yi, Zhu Keyu, Wan Heng, Wang Yuying, Wang Ningjian et al. "Testosterone Deficiency Promotes Hypercholesteremia and Attenuates Cholesterol Liver Uptake via AR/PCSK9/LDLR Pathways". International Journal of Endocrinology 2022 (13 de mayo de 2022): 1–10. http://dx.doi.org/10.1155/2022/7989751.
Texto completoDrew-Nord, Dana C., OiSaeng Hong, Erika S. Froelicher, Phyllis Berryman y Eileen Lukes. "Cardiovascular Risk Factors among Career Firefighters". AAOHN Journal 57, n.º 10 (octubre de 2009): 415–24. http://dx.doi.org/10.1177/216507990905701004.
Texto completoBardia, A. y G. Garg. "Mipomersen For Treatment Of Hypercholesteremia: Evidence Review And Meta Analytic Evaluation Of Randomized Controlled Trials". Value in Health 18, n.º 3 (mayo de 2015): A132. http://dx.doi.org/10.1016/j.jval.2015.03.771.
Texto completoNaik, Aleš Belič Adviti. "Analysis of the Cholesterol Biosynthesis Feedback Control and its Consequences for the Hypercholesteremia Treatment Strategies". IFAC Proceedings Volumes 45, n.º 2 (2012): 624–28. http://dx.doi.org/10.3182/20120215-3-at-3016.00111.
Texto completoHuige, M. C., J. J. R. M. Bonnier, H. J. Rila, L. J. Jansen, K. te VElde, A. J. te Rijdt, P. de Weerd y P. A. Leijten. "Efficacy and safety of pravastatin in Dutch patients with hypercholesteremia and additional coronary risk factors". Atherosclerosis 115 (junio de 1995): S128. http://dx.doi.org/10.1016/0021-9150(95)96739-f.
Texto completoCheung, Brian, Jay Hwang, Ania Stolarczyk, Elliot Mahlof y Robert Block. "Case Study of Hypertriglyceridemia from COVID-19 Pfizer-BioNTech Vaccination in a Patient with Familial Hypercholesteremia". Journal of Clinical Lipidology 16, n.º 1 (enero de 2022): e13-e14. http://dx.doi.org/10.1016/j.jacl.2021.09.019.
Texto completoKirkorowicz, JM, P. Sapukotana, PV De Silva, M. Noda, JS De Oliveira y T. Østbye. "Work-Related Stress and Substance Use as Risk Factors for Chronic Disease Among Three-Wheel Drivers in Galle, Sri Lanka: A Qualitative Study". International Journal of Occupational Safety and Health 3, n.º 2 (10 de febrero de 2014): 21–24. http://dx.doi.org/10.3126/ijosh.v3i2.7662.
Texto completoEzratty, Ellen J., Claire Bertaux, Eugene E. Marcantonio y Gregg G. Gundersen. "Clathrin mediates integrin endocytosis for focal adhesion disassembly in migrating cells". Journal of Cell Biology 187, n.º 5 (30 de noviembre de 2009): 733–47. http://dx.doi.org/10.1083/jcb.200904054.
Texto completoCHISAKA, TAKESHI, HISASHI MATSUDA, YASUSHI KUBOMURA, MICHIHIKO MOCHIZUKI, JOHJI YAMAHARA y HAJIME FUJIMURA. "The effect of crude drugs on experimental hypercholesteremia: Mode of action of (-)-epigallocatechin gallate in tea leaves." CHEMICAL & PHARMACEUTICAL BULLETIN 36, n.º 1 (1988): 227–33. http://dx.doi.org/10.1248/cpb.36.227.
Texto completoWeng, Pei-Hsuan, Jen-Hau Chen, Ta-Fu Chen, Yu Sun, Li-Li Wen, Ping-Keung Yip, Yi-Min Chu y Yen-Ching Chen. "P3-253: Interactions between ApoE ε4 status and hypercholesteremia on response to acetylcholinesterase inhibitor in Alzheimer's disease". Alzheimer's & Dementia 11, n.º 7S_Part_16 (julio de 2015): P728. http://dx.doi.org/10.1016/j.jalz.2015.06.1626.
Texto completoMIYAMURA, Mitsuhiko, Hironori MORIYAMA, Shuuzo MURATA, Junko YOKOTA, Saburo YOSHIOKA, Daisuke TAKUMA, Atsuhide HAMADA y Yutaka NISHIOKA. "Inhibitory Effects of “Goishi-tea” as a Post-Fermented-tea on Dietary-Induced Hypercholesteremia and Atherosclerosis in Rabbits". YAKUGAKU ZASSHI 128, n.º 7 (1 de julio de 2008): 1037–44. http://dx.doi.org/10.1248/yakushi.128.1037.
Texto completoAhualli, L., A. Stewart-Harris, G. Bastianelli, D. Radlovachki, A. Bartolomé, P. L. Trigo, N. Cejas et al. "Combined Cardiohepatic Transplantation Due to Severe Heterozygous Familiar Hypercholesteremia Type II: First Case in Argentina—A Case Report". Transplantation Proceedings 39, n.º 7 (septiembre de 2007): 2449–53. http://dx.doi.org/10.1016/j.transproceed.2007.07.068.
Texto completoMatlock, John P. y J. E. Nixon. "Impaired clearance, elimination, and metabolism of plasma cholesterol esters associated with hypercholesteremia in mice fed cyclopropenoid fatty acids". Toxicology and Applied Pharmacology 84, n.º 1 (junio de 1986): 3–11. http://dx.doi.org/10.1016/0041-008x(86)90411-4.
Texto completoKamal, Shymaa, Ragaa A. Hamouda, Hoda Mahrous, Mohammed Labib Salem, Hanafy A. Hamza y Ekbal Abd Elhafez. "In vitro Treatment with Intact Cells or Cell Lysates of Lactobacillus and Spirulina Induced Lowering Effects on Induced Hypercholesteremia". International Journal of Pharmacology 11, n.º 6 (1 de agosto de 2015): 638–43. http://dx.doi.org/10.3923/ijp.2015.638.643.
Texto completoKim, Beob-Jin, Yeon-Kye Kim, Won-Hwan Park, Jeong-Heon Ko, Young-Choon Lee y Cheorl-Ho Kim. "A water-extract of the Korean traditional formulation Geiji–Bokryung–Hwan reduces atherosclerosis and hypercholesteremia in cholesterol-fed rabbits". International Immunopharmacology 3, n.º 5 (mayo de 2003): 723–34. http://dx.doi.org/10.1016/s1567-5769(03)00073-0.
Texto completoGopinathanpillai, Kalavarasariel, Eluri Kalpana, Balasubramaniam Dineshkumar, Elumalai Monogaran, Govindharajalu Geetha y Ramasamy Venkatanarayanan. "Tetrahydrocurcumin: Beneficial Effects on HMG-CoA Reductase enzyme and Lipoprotein Lipase Enzymes in High-fat diet-induced Hypercholesteremia Rabbits". Pharmacognosy Communications 2, n.º 2 (19 de abril de 2012): 50–60. http://dx.doi.org/10.5530/pc.2012.2.8.
Texto completoLi, Yun-Xi, Chao-Qun Lin, Da-Yu Shi, Shu-Ying Zeng y Wen-Sheng Li. "Upregulated expression of human alpha-defensins 1, 2 and 3 in hypercholesteremia and its relationship with serum lipid levels". Human Immunology 75, n.º 11 (noviembre de 2014): 1104–9. http://dx.doi.org/10.1016/j.humimm.2014.09.014.
Texto completoWeintraub, Spencer, Jessica A. Schillow, Bani Azari y Benjamin Hirsh. "IMPLEMENTATION TIMELINE OF NOVEL LIPID LOWERING THERAPIES IN A REFRACTORY COMPOUND HETEROZYGOUS FAMILIAL HYPERCHOLESTEREMIA PATIENT WITH SEVERE ATHEROSCLEROTIC CARDIOVASCULAR DISEASE". Journal of the American College of Cardiology 79, n.º 9 (marzo de 2022): 3186. http://dx.doi.org/10.1016/s0735-1097(22)04177-8.
Texto completoRani, Pratibha, Kamaldeep Singh, Anania Arjuna y Savita Devi. "GENETIC DISORDER ALZHEIMER". Asian Journal of Pharmaceutical and Clinical Research 10, n.º 12 (1 de diciembre de 2017): 36. http://dx.doi.org/10.22159/ajpcr.2017.v10i12.18684.
Texto completo